Zepatier

Chemical Nameelbasvir and grazoprevir
Dosage FormTablet (oral; elbasvir mg/grazoprevir mg: 50 mg/100 mg)
Drug ClassAntivirals
SystemDigestive
CompanyMerck & Co.
Approval Year2016

Indication

  • To treat patients with chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.
Last updated on 12/18/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Zepatier (elbasvir and grazoprevir) Prescribing Information2019Merck Sharp & Dohme Corp.